---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-267279"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T04:08:39.828033+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics board authorizes $500K share repurchase program

## Summary
- Board approved repurchase of up to $500,000 of common stock over 12 months.
- Repurchases may be made on open market or privately, subject to lender consent.
- Company not obligated to buy any shares; program can be discontinued at any time.

## SEC filing metadata
- accession: 0001193125-23-267279
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312523267279/0001193125-23-267279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312523267279/d572000d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-267279
- JSON: https://secwatch.observer/filing/0001193125-23-267279.json
- Plain text: https://secwatch.observer/filing/0001193125-23-267279.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.